WWE Superstar Bill Goldberg Launches Partnership With CBD Wellness Brand Gallant and Hemp2lab

1.3 min readPublished On: August 8th, 2022By

NEW YORK – Bill Goldberg, WWE Hall of Famer is making the transition from the squared circle to the wellness mat. Goldberg is redefining himself through his partnership with Hemp2Lab to launch a new wellness line of products – GALLANT – that are scientifically designed to maximize nutrient delivery and athletic performance.

“Throughout my career, I’ve maximized my performance through proper training, and by paying a lot of attention to what I put into my body. I’m proud to partner with Hemp2Lab on developing this exceptional product line that can turbocharge your performance and improve everyday life,” said Goldberg.

 

The Gallant products are powered by a breakthrough liposomal delivery technology (element6), which provides up to 10 times higher absorption and maximum nutrient delivery into the body. This new generation liposomal accelerates the delivery of nutrients into the bloodstream for fast acting results.

“Many CBD and nutritional supplement products do not meet consumer expectations. Gallant products are tailored for discerning consumers who expect high performance and uncompromising quality, safety, and consistency. The Gallant line is great value for the money” Says Bill Margaritis, CEO of Hemp2Lab.

Goldberg and Gallant are dedicated in delivering the highest quality of natural ingredients, THC Free organic hemp, vegan, gluten free, and made in the USA.

Gallant’s initial product line includes the following:

Without CBD:

  • Pre-workout supplement
  • Immune boost supplement

With CBD:

  • Sleep Improvement
  • Muscle relief cream
  • Gummies
  • Pure Oil Tincture
  • Joint relief salve

(This information is primarily sourced from Hemp2Lab.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!